ProQR Therapeutics (PRQR) Enterprise Value (QoQ) (2013 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 2.70% |
| Sep 30, 2023 | 6.33% |
| Jun 30, 2023 | 6.29% |
| Mar 31, 2023 | -52.90% |
| Dec 31, 2022 | 48.22% |
| Sep 30, 2022 | -13.22% |
| Jun 30, 2022 | 20.71% |
| Mar 31, 2022 | 3.79% |
| Dec 31, 2021 | -31.11% |
| Sep 30, 2021 | -79.16% |
| Jun 30, 2021 | -1.96% |
| Mar 31, 2021 | -0.06% |
| Dec 31, 2020 | 30.76% |
| Sep 30, 2020 | -7.08% |
| Jun 30, 2020 | 99.90% |
| Mar 31, 2020 | -99,633.61% |
| Dec 31, 2019 | -5.48% |
| Sep 30, 2019 | 0.97% |
| Jun 30, 2019 | 1.14% |
| Mar 31, 2019 | 0.42% |
| Dec 31, 2018 | -115.40% |
| Sep 30, 2018 | 2.54% |
| Jun 30, 2018 | 100.00% |
| Mar 31, 2018 | -104,339,874.00% |
| Dec 31, 2017 | 100.00% |
| Sep 30, 2017 | -106,867,717,539,816.94% |
| Jun 30, 2017 | 99.90% |
| Mar 31, 2017 | 99.90% |
| Dec 31, 2016 | -88,109.10% |
| Dec 31, 2015 | 99.92% |
| Mar 31, 2015 | 8.74% |
| Dec 31, 2014 | -177.95% |
| Mar 31, 2014 | -0.68% |
| Dec 31, 2013 | -59.51% |